Last 12 months
Inside the activity.
0 purchase rows · 27 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 10 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 03, 2025 Filed Oct 3, 2025 21:37 UTC |
Patel NaimishChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,500 | $0.00 Strike: $67.74 | $0.00 |
DisclosureSEC source: 0001193125-25-230508 · ownership.xml · derivative · entry 1 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Shares · 16,500 shares Expires 2035-10-03 F1 · derivative.exercise_date: This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025. Read SEC document |
| October 03, 2025 Filed Oct 3, 2025 21:38 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 49,500 | $0.00 Strike: $67.74 | $0.00 |
DisclosureSEC source: 0001193125-25-230511 · ownership.xml · derivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,500 Underlying: Common Shares · 49,500 shares Expires 2035-10-03 F1 · derivative.exercise_date: This option was granted on October 3, 2025 with respect to 49,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025. Read SEC document |
| October 03, 2025 Filed Oct 3, 2025 21:36 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
GrantStock Option (Right to Buy) · Derivative | 16,500 | $0.00 Strike: $67.74 | $0.00 |
DisclosureSEC source: 0001193125-25-230506 · ownership.xml · derivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Shares · 16,500 shares Expires 2035-10-03 F1 · derivative.exercise_date: This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025. Read SEC document |
| October 03, 2025 Filed Oct 3, 2025 21:36 UTC |
Prasad RajuChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,500 | $0.00 Strike: $67.74 | $0.00 |
DisclosureSEC source: 0001193125-25-230505 · ownership.xml · derivative · entry 1 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Shares · 16,500 shares Expires 2035-10-03 F1 · derivative.exercise_date: This option was granted on October 3, 2025 with respect to 16,500 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of November 3, 2025. Read SEC document |
| September 17, 2025 Filed Sep 19, 2025 21:42 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
GiftCommon Shares | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-209353 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,004 F1 · shares: The reporting person made a charitable contribution of common shares to a donor advised fund. Read SEC document |
| August 18, 2025 Filed Aug 19, 2025 20:30 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 13,081 | $58.15 | $760,660.15 |
DisclosureSEC source: 0001682019-25-000003 · ownership.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,004 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| August 16, 2025 Filed Aug 19, 2025 20:30 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682019-25-000003 · ownership.xml · derivative · entry 4 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 25,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on August 16, 2022 with respect to 25,000 Common Shares, with 100% of the shares vesting on August 16, 2025. F3 · derivative.expiration_date: This restricted stock unit award was granted on August 16, 2022 with respect to 25,000 Common Shares, with 100% of the shares vesting on August 16, 2025. Read SEC document |
| August 16, 2025 Filed Aug 19, 2025 20:30 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 25,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001682019-25-000003 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 220,085 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| August 06, 2025 Filed Sep 21, 2026 22:30 UTC |
Behbahani AliDirector
|
OtherCommon Shares | 15 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-396935 · ownership.xml · nonDerivative · entry 2 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Note 3 Disclosed balance after: 29 F2 · kind: The Ali Behbahani Revocable Trust Dated June 26, 2015 (the "Behbahani Trust") received 15 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025. F3 · ownership.nature: The Reporting Person is the trustee of the Behbahani Trust, which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, of such portion of the Common Shares of the Issuer held by the Behbahani Trust in which the Reporting Person has no pecuniary interest. Read SEC document |
| August 06, 2025 Filed Sep 21, 2026 22:30 UTC |
Behbahani AliDirector
|
OtherCommon Shares | 60 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-396935 · ownership.xml · nonDerivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316 F1 · kind: NEA Partners 15, L.P. ("NEA Partners 15") made a pro rata distribution for no consideration of Common Shares of the Issuer to its limited partners on August 6, 2025. The Reporting Person received 60 Common Shares of the Issuer in the distribution by NEA Partners 15 on August 6, 2025. Read SEC document |
| August 06, 2025 Filed Aug 8, 2025 20:06 UTC |
Treco Douglas ADirector
|
PurchaseCommon Shares | 20,000 | $57.03 | $1,140,600.00 |
DisclosureSEC source: 0001688192-25-000004 · ownership.xml · nonDerivative · entry 1 Treco Douglas A · CIK 0001688192 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 F1 · kind: Open market purchase of shares in accordance with Issuer's trading policies. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.92 to $57.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 21:19 UTC |
George SimeonDirector
|
PurchaseCommon Shares | 960,983 | $52.03 | $49,999,945.49 |
DisclosureSEC source: 0000950170-25-096666 · ownership.xml · nonDerivative · entry 3 George Simeon · CIK 0001595117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Note 3 Disclosed balance after: 1,730,179 F3 · ownership.nature: The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital SMA Partners, LP ("SMA Partners"). SMA Partners is the sole general partner of AMZL, LP ("AMZL"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by AMZL in which the Reporting Person has no pecuniary interest. Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 21:19 UTC |
George SimeonDirector
|
PurchaseCommon Shares | 22,319 | $52.03 | $1,161,257.57 |
DisclosureSEC source: 0000950170-25-096666 · ownership.xml · nonDerivative · entry 2 George Simeon · CIK 0001595117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Note 2 Disclosed balance after: 238,897 F2 · ownership.nature: The Reporting Person is the sole managing member of SR One Capital Management, which is the sole general partner of SR One Capital Opportunities Partners I, LP ("SR One Opportunities Partners I"). SR One Opportunities Partners I is the sole general partner of SR One Capital Opportunities Fund I, LP ("SR One Opportunities Fund I"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 or otherwise of such portion of the securities held by SR One Opportunities Fund I in which the Reporting Person has no pecuniary interest. Read SEC document |
| July 16, 2025 Filed Jul 17, 2025 21:19 UTC |
George SimeonDirector
|
PurchaseCommon Shares | 6,510 | $52.03 | $338,715.30 |
DisclosureSEC source: 0000950170-25-096666 · ownership.xml · nonDerivative · entry 1 George Simeon · CIK 0001595117 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Note 1 Disclosed balance after: 69,687 F1 · ownership.nature: The Reporting Person is the sole managing member of SR One Capital Management, LLC ("SR One Capital Management"), which is the sole general partner of SR One Capital Partners II, LP ("SR One Partners II"). SR One Partners II is the sole general partner of SR One Capital Fund II Aggregator, LP ("SR One Fund II Aggregator"), which is the direct beneficial owner of the securities. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended ("Section 16"), or otherwise of such portion of the securities held by SR One Fund II Aggregator in which the Reporting Person has no pecuniary interest. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:30 UTC |
Rommel ChristianDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083272 · ownership.xml · derivative · entry 1 Rommel Christian · CIK 0002022449 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:30 UTC |
Treco Douglas ADirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083273 · ownership.xml · derivative · entry 1 Treco Douglas A · CIK 0001688192 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:47 UTC |
George SimeonDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083298 · ownership.xml · derivative · entry 1 George Simeon · CIK 0001595117 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:38 UTC |
Behbahani AliDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083289 · ownership.xml · derivative · entry 1 Behbahani Ali · CIK 0001613867 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:30 UTC |
Morrison BriggsDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083274 · ownership.xml · derivative · entry 1 Morrison Briggs · CIK 0001654430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:30 UTC |
Fleming Harold EdwardDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083271 · ownership.xml · derivative · entry 1 Fleming Harold Edward · CIK 0001857250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:30 UTC |
Mahatme SandeshDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083269 · ownership.xml · derivative · entry 1 Mahatme Sandesh · CIK 0001511034 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:30 UTC |
Greene JohnDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083270 · ownership.xml · derivative · entry 1 Greene John · CIK 0001610732 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:30 UTC |
Fardis MariaDirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083268 · ownership.xml · derivative · entry 1 Fardis Maria · CIK 0001559231 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| June 05, 2025 Filed Jun 6, 2025 21:30 UTC |
High Katherine ADirector
|
GrantStock Option (Right to Buy) · Derivative | 13,000 | $0.00 Strike: $38.57 | $0.00 |
DisclosureSEC source: 0000950170-25-083267 · ownership.xml · derivative · entry 1 High Katherine A · CIK 0001631248 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Shares · 13,000 shares Expires 2035-06-05 F1 · derivative.exercise_date: This option was granted on June 5, 2025 with respect to 13,000 Common Shares, with 100% of the shares vesting in 12 equal monthly installments beginning on June 30, 2025; provided that the last installment will vest on the earlier of (i) the one year anniversary of the date of grant or (ii) the date of the 2026 Annual General Meeting of Shareholders. Read SEC document |
| May 30, 2025 Filed Jun 4, 2025 01:45 UTC |
Patel NaimishChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081361 · ownership.xml · derivative · entry 1 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Shares · 25,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · derivative.exercise_date: This restricted stock unit award was granted on May 30, 2025 with respect to 25,000 Common Shares, with 100% of the shares vesting on May 30, 2028. F2 · derivative.expiration_date: This restricted stock unit award was granted on May 30, 2025 with respect to 25,000 Common Shares, with 100% of the shares vesting on May 30, 2028. Read SEC document |
| May 30, 2025 Filed Jun 4, 2025 01:45 UTC |
Prasad RajuChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-081362 · ownership.xml · derivative · entry 1 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 20,000 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F2 · derivative.exercise_date: This restricted stock unit award was granted on May 30, 2025 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 30, 2028. F2 · derivative.expiration_date: This restricted stock unit award was granted on May 30, 2025 with respect to 20,000 Common Shares, with 100% of the shares vesting on May 30, 2028. Read SEC document |
| May 29, 2025 Filed May 30, 2025 21:00 UTC |
Patel NaimishChief Medical Officer
|
SaleCommon Shares | 3,932 | $35.94 | $141,316.08 |
DisclosureSEC source: 0000950170-25-079822 · ownership.xml · nonDerivative · entry 2 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,068 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:00 UTC |
Patel NaimishChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-079822 · ownership.xml · derivative · entry 3 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Shares · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028. F3 · derivative.expiration_date: This restricted stock unit award was granted on May 28, 2024 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on May 28, 2025, (ii) one quarter of the shares vesting on May 28, 2026, (iii) one quarter of the shares vesting on May 28, 2027, and (iv) one quarter of the shares vesting on May 28, 2028. Read SEC document |
| May 28, 2025 Filed May 30, 2025 21:00 UTC |
Patel NaimishChief Medical Officer
|
Exercise / conversionCommon Shares | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-079822 · ownership.xml · nonDerivative · entry 1 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| April 03, 2025 Filed Jan 27, 2026 22:35 UTC |
Patel NaimishChief Medical Officer
|
PurchaseCommon Shares | 1,508 | $32.96 | $49,703.68 |
DisclosureSEC source: 0001193125-26-024955 · ownership.xml · nonDerivative · entry 1 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,508 F1 · kind: The purchase of Common Shares reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 1,508 shares, with a subsequent sale of Common Shares at a price of $35.94 per share on May 29, 2025 pursuant to a mandatory "sell to cover" provision in an award agreement covering a restricted stock unit that vested on such date (and which was reported on a separate Form 4 filing dated May 30, 2025). The Reporting Person has agreed to pay to the Issuer $4,493.84, representing the full amount of the profit realized in connection with the short-swing transaction. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 17:35 UTC |
Bruno JulianneChief Operating Officer
|
SaleCommon Shares | 1,714 | $41.23 | $70,668.22 |
DisclosureSEC source: 0000950170-25-043974 · ownership.xml · nonDerivative · entry 2 Bruno Julianne · CIK 0002019645 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,544 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
SaleCommon Shares | 10,031 | $41.23 | $413,578.13 |
DisclosureSEC source: 0000950170-25-043975 · ownership.xml · nonDerivative · entry 2 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,085 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 21:35 UTC |
Prasad RajuChief Financial Officer
|
SaleCommon Shares | 2,197 | $41.23 | $90,582.31 |
DisclosureSEC source: 0000950170-25-043973 · ownership.xml · nonDerivative · entry 2 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,767 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 21, 2025 Filed Mar 24, 2025 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
SaleCommon Shares | 3,185 | $41.23 | $131,317.55 |
DisclosureSEC source: 0000950170-25-043972 · ownership.xml · nonDerivative · entry 2 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,729 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 17:35 UTC |
Bruno JulianneChief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-043974 · ownership.xml · derivative · entry 4 Bruno Julianne · CIK 0002019645 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,250 Underlying: Common Shares · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on March 20, 2024 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028. F3 · derivative.expiration_date: This restricted stock unit award was granted on March 20, 2024 with respect to 15,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 17:35 UTC |
Bruno JulianneChief Operating Officer
|
Exercise / conversionCommon Shares | 3,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-043974 · ownership.xml · nonDerivative · entry 1 Bruno Julianne · CIK 0002019645 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,258 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 19,688 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-043975 · ownership.xml · derivative · entry 4 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,062 Underlying: Common Shares · 19,688 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028. F3 · derivative.expiration_date: This restricted stock unit award was granted on March 20, 2024 with respect to 78,750 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:35 UTC |
Kulkarni SamarthDirector · Chief Executive Officer
|
Exercise / conversionCommon Shares | 19,688 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-043975 · ownership.xml · nonDerivative · entry 1 Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,116 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:35 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-043973 · ownership.xml · derivative · entry 3 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Shares · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028. F3 · derivative.expiration_date: This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:35 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionCommon Shares | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-043973 · ownership.xml · nonDerivative · entry 1 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionRestricted Stock Units · Derivative | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-043972 · ownership.xml · derivative · entry 3 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,750 Underlying: Common Shares · 6,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028. F3 · derivative.expiration_date: This restricted stock unit award was granted on March 20, 2024 with respect to 25,000 Common Shares, with (i) one quarter of the shares vesting on March 20, 2025, (ii) one quarter of the shares vesting on March 20, 2026, (iii) one quarter of the shares vesting on March 20, 2027, and (iv) one quarter of the shares vesting on March 20, 2028. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:35 UTC |
KASINGER JAMES R.General Counsel and Secretary
|
Exercise / conversionCommon Shares | 6,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-043972 · ownership.xml · nonDerivative · entry 1 KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 21:35 UTC |
Prasad RajuChief Financial Officer
|
SaleCommon Shares | 3,762 | $41.80 | $157,251.60 |
DisclosureSEC source: 0000950170-25-041471 · ownership.xml · nonDerivative · entry 2 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,714 F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:35 UTC |
Patel NaimishChief Medical Officer
|
GrantRestricted Stock Units · Derivative | 32,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-041470 · ownership.xml · derivative · entry 2 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,500 Underlying: Common Shares · 32,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. F3 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 32,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:35 UTC |
Patel NaimishChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 46,667 | $0.00 Strike: $42.12 | $0.00 |
DisclosureSEC source: 0000950170-25-041470 · ownership.xml · derivative · entry 1 Patel Naimish · CIK 0002021679 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,667 Underlying: Common Shares · 46,667 shares Expires 2035-03-14 F1 · derivative.exercise_date: This option was granted on March 14, 2025 with respect to 46,667 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 17:35 UTC |
Bruno JulianneChief Operating Officer
|
GrantRestricted Stock Units · Derivative | 27,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-041468 · ownership.xml · derivative · entry 2 Bruno Julianne · CIK 0002019645 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Shares · 27,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. F3 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 17:35 UTC |
Bruno JulianneChief Operating Officer
|
GrantStock Option (Right to Buy) · Derivative | 36,666 | $0.00 Strike: $42.12 | $0.00 |
DisclosureSEC source: 0000950170-25-041468 · ownership.xml · derivative · entry 1 Bruno Julianne · CIK 0002019645 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,666 Underlying: Common Shares · 36,666 shares Expires 2035-03-14 F1 · derivative.exercise_date: This option was granted on March 14, 2025 with respect to 36,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:35 UTC |
Prasad RajuChief Financial Officer
|
GrantRestricted Stock Units · Derivative | 27,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-041471 · ownership.xml · derivative · entry 5 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Shares · 27,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F5 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. F5 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2025 with respect to 27,500 Common Shares, with (i) one quarter of the shares vesting on March 14, 2026, (ii) one quarter of the shares vesting on March 14, 2027, (iii) one quarter of the shares vesting on March 14, 2028, and (iv) one quarter of the shares vesting on March 14, 2029. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:35 UTC |
Prasad RajuChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 36,666 | $0.00 Strike: $42.12 | $0.00 |
DisclosureSEC source: 0000950170-25-041471 · ownership.xml · derivative · entry 4 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,666 Underlying: Common Shares · 36,666 shares Expires 2035-03-14 F4 · derivative.exercise_date: This option was granted on March 14, 2025 with respect to 36,666 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 14, 2025. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 21:35 UTC |
Prasad RajuChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-041471 · ownership.xml · derivative · entry 3 Prasad Raju · CIK 0001968317 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares. F3 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027. F3 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.